We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+2.56%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$23B
AUM Growth
+$654M
Cap. Flow
+$6.71M
Cap. Flow %
0.03%
Top 10 Hldgs %
15.45%
Holding
1,532
New
151
Increased
540
Reduced
484
Closed
141

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$284M
2
DB icon
Deutsche Bank
DB
+$159M
3
NSC icon
Norfolk Southern
NSC
+$108M
4
HPQ icon
HP
HPQ
+$92.2M
5
DD
Du Pont De Nemours E I
DD
+$80.9M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$161M
2
F icon
Ford
F
+$87.9M
3
WHR icon
Whirlpool
WHR
+$74M
4
PNC icon
PNC Financial Services
PNC
+$72.9M
5
EMN icon
Eastman Chemical
EMN
+$72.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.62%
2 Technology 14.22%
3 Financials 13.17%
4 Industrials 11.49%
5 Energy 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGU
251
DELISTED
Agrium
AGU
$19.4M 0.08%
199,061
+66,066
+50% +$6.05M
HP icon
252
Helmerich & Payne
HP
$4.35B
$19.4M 0.08%
180,589
-3,392
-2% -$315K
HUM icon
253
Humana
HUM
$47.7B
$19.4M 0.08%
172,000
-383,352
-69% -$39.9M
IHS
254
DELISTED
IHS INC CL-A COM STK
IHS
$19.3M 0.08%
159,000
+100,000
+169% +$11.8M
CMG icon
255
Chipotle Mexican Grill
CMG
$44.1B
$19.2M 0.08%
1,691,600
-208,250
-11% -$2.3M
UPS icon
256
United Parcel Service
UPS
$87.1B
$18.8M 0.08%
192,641
+16,053
+9% +$1.56M
MRSH
257
Marsh
MRSH
$85.8B
$18.4M 0.08%
373,500
+328,500
+730% +$15.7M
DUK icon
258
Duke Energy
DUK
$91.8B
$18.3M 0.08%
257,303
-15,697
-6% -$1.09M
WLL
259
DELISTED
Whiting Petroleum Corporation
WLL
$18.3M 0.08%
880
-218
-20% -$4.13M
AET
260
DELISTED
Aetna Inc
AET
$18.3M 0.08%
243,982
-285,706
-54% -$20.2M
SYK icon
261
Stryker
SYK
$108B
$18.2M 0.08%
222,980
+3,972
+2% +$316K
WHR icon
262
Whirlpool
WHR
$2.15B
$18.2M 0.08%
121,500
-511,160
-81% -$74M
BEAM
263
DELISTED
BEAM INC COM STK (DE)
BEAM
$18.1M 0.08%
217,769
TDG icon
264
TransDigm Group
TDG
$60B
$18.1M 0.08%
97,514
-5,000
-5% -$874K
COV
265
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$18M 0.08%
243,724
+38,486
+19% +$2.68M
MR
266
DELISTED
MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A
MR
$17.9M 0.08%
554,007
-30,526
-5% -$1.07M
SO icon
267
Southern Company
SO
$98.9B
$17.9M 0.08%
407,966
+17,334
+4% +$727K
PARA
268
DELISTED
Paramount Global Class B
PARA
$17.8M 0.08%
287,735
+15,435
+6% +$974K
ALL icon
269
Allstate
ALL
$65B
$17.4M 0.08%
307,400
+273,700
+812% +$14.7M
ENDP
270
DELISTED
Endo International plc
ENDP
$17.3M 0.08%
252,640
-461,588
-65% -$32.7M
VRTX icon
271
Vertex Pharmaceuticals
VRTX
$130B
$17.1M 0.07%
242,188
+12,613
+5% +$999K
ALKS icon
272
Alkermes
ALKS
$7.73B
$17.1M 0.07%
387,695
+64,218
+20% +$3.06M
NOW icon
273
ServiceNow
NOW
$147B
$17M 0.07%
1,420,000
-270,000
-16% -$3.44M
NEE icon
274
NextEra Energy
NEE
$169B
$16.8M 0.07%
703,984
-36,132
-5% -$819K
ELV icon
275
Elevance Health
ELV
$90.5B
$16.8M 0.07%
168,715
-6,561
-4% -$593K

Similar funds

Axa's Q1 2014 Portfolio in Review

As of Q1 2014, Axa held 1,532 positions worth $23B, up 2.9% from $22.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Axa's Q1 2014 filing shows 151 new, 540 increased, 484 reduced and 141 closed positions. Its largest new stake was Celanese: 949,936 shares worth $52.7M. The largest sale was Eli Lilly, an estimated $161M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q1 2014 buy was Celanese: 949,936 shares worth $52.7M.
  • Axa added most to Verizon in Q1 2014, an estimated $284M increase.
  • Axa's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $161M.
  • Axa fully exited Avon Products, Inc. in Q1 2014, selling an estimated $53.7M.
  • Axa's ten largest holdings make up 15% of its $23B portfolio in Q1 2014.
  • Axa opened 151 new positions and closed 141 in Q1 2014.
  • Axa's portfolio value rose 2.9% quarter-over-quarter to $23B.

Based on Axa's 13F filing for Q1 2014, filed 13 May 2014.